M&A Deal Summary

Physicians Interactive Acquires Univadis

On October 21, 2015, Physicians Interactive acquired information technology company Univadis from Merck

Acquisition Highlights
  • This is Physicians Interactive’s 3rd transaction in the Information Technology sector.
  • This is Physicians Interactive’s 7th transaction in the United States.

M&A Deal Summary

Date 2015-10-21
Target Univadis
Sector Information Technology
Buyer(s) Physicians Interactive
Sellers(s) Merck
Deal Type Divestiture

Target

Univadis

United States
Univadis is a provider of IT based platform for healthcare professional (HCP) network.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Physicians Interactive

Reading, Massachusetts, United States

Category Company
Founded 1995
Sector Information Technology
DESCRIPTION

Physicians Interactive, Inc. is a provider of digital sales and marketing solutions for pharmaceutical, biotech and medical device companies to reach physicians and other healthcare professionals via the internet. PI has developed more than 1,000 online programs for more than 150 brands throughout every stage of the product life cycle.


DEAL STATS #
Overall 7 of 7
Sector: Information Technology M&A 3 of 3
Type: Divestiture M&A Deals 1 of 1
Country: United States M&A 7 of 7
Year: 2015 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-23 Quantia

Waltham, Massachusetts, United States

Quantia, Inc. is a provider of web and mobile technology solutions for health care industry.

Buy -

Seller(S) 1

SELLER

Merck

Rahway, New Jersey, United States

Category Company
Founded 1891
Sector Life Science
Employees70,000
Revenue 64.2B USD (2024)
DESCRIPTION
Merck office in Palo Alto, California.
Merck office in Palo Alto, California.

Merck is a global healthcare company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The Company’s operations are comprised of four operating segments: Pharmaceutical, Animal Health, Consumer Care and Alliances. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The Company also has animal health operations that discover, develop, manufacture and market animal health products, including vaccines, which the Company sells to veterinarians, distributors and animal producers. Additionally, the Company has consumer care operations that develop, manufacture and market over-the-counter, foot care and sun care products. Merck was established in 1891 and is based in Rahway, New Jersey.


DEAL STATS #
Overall 4 of 7
Sector: Information Technology M&A 1 of 1
Type: Divestiture M&A Deals 4 of 6
Country: United States M&A 4 of 7
Year: 2015 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-09-21 Merck - Two NDAs

United States

Merck - Two NDAs consist of Corticotropin gel is a purified corticotropin (ACTH) in a sterile solution of gelatin for prolonged activity and Corticotropin-zinc hydroxide (sterile corticotropin zinc hydroxide suspension USP) is a sterile aqueous suspension of purified corticotropin (ACTH) with zinc hydroxide for repository action.

Sell $75M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-01-11 IOmet Pharma

Edinburgh, United Kingdom

IOmet Pharma Ltd. is a drug discovery company focused on the development of innovative medicines for the treatment of cancer, with particular emphasis on the fields of cancer immunotherapy and cancer metabolism.

Buy -